博客

  • PGT-SR for Balanced Translocation Carriers: What to Ask and Consider

    Understanding PGT-SR and Balanced Translocations

    If you or your partner carry a balanced translocation, you may have been told that PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) could help during IVF. This test is designed to identify embryos that have a normal or balanced set of chromosomes, avoiding those with an unbalanced rearrangement that could lead to miscarriage or a child with health problems.

    PGT-SR is not a guarantee of a successful pregnancy or a healthy baby. It is one option to consider, and it requires careful discussion with your fertility team and a genetic counselor.

    At a Glance

    • PGT-SR is a genetic test performed on embryos created through IVF.
    • It aims to detect embryos with unbalanced chromosome rearrangements.
    • It does not test for all genetic conditions or guarantee a live birth.
    • Your clinic will need to confirm the exact testing platform and its limitations.

    What Is a Balanced Translocation?

    A balanced translocation is a chromosomal rearrangement where pieces of chromosomes have swapped places, but the total amount of genetic material is normal. Carriers usually have no health problems themselves, but they may produce eggs or sperm with unbalanced chromosomes, which can lead to miscarriage or a child with disabilities.

    PGT-SR is specifically designed for this situation, but it is not the only option. Some carriers may consider prenatal testing after natural conception, or they may choose not to test at all. The right choice depends on your personal, medical, and ethical considerations.

    How PGT-SR Works

    PGT-SR is performed as part of an IVF cycle. After eggs are fertilized, embryos are cultured for several days. A few cells are then biopsied from each embryo and sent for genetic analysis. The test looks for the specific translocation you carry, aiming to identify embryos with a normal or balanced chromosome pattern.

    The process involves several steps, and your clinic will guide you through each one. It is important to understand that the test is not 100% accurate, and there is a small risk of misdiagnosis. Your clinic should explain the laboratory methods they use and the quality controls in place.

    What PGT-SR Can and Cannot Tell You

    PGT-SR can identify embryos that appear to have a normal or balanced chromosome set for the translocation in question. However, it cannot guarantee that an embryo is completely free of all genetic or chromosomal issues. It also does not test for single-gene disorders or other chromosomal abnormalities unrelated to the translocation.

    Furthermore, PGT-SR does not guarantee implantation, pregnancy, or a live birth. Embryo quality, uterine factors, and other medical issues also play a role. The test is a screening tool, not a cure.

    Alternatives to PGT-SR

    If you are a balanced translocation carrier, you may have other options:

    • Natural conception with prenatal testing: You could conceive naturally and undergo chorionic villus sampling (CVS) or amniocentesis during pregnancy to check the baby’s chromosomes.
    • IVF without PGT-SR: You could have IVF and transfer embryos without genetic testing, accepting the risk of an unbalanced embryo.
    • Using donor eggs or sperm: Some carriers choose to use a donor to avoid passing on the translocation.
    • Not testing: You may decide not to pursue any testing and accept the natural risks.

    Each option has its own benefits and drawbacks. A genetic counselor can help you weigh them based on your specific translocation and personal values.

    Questions to Ask Your Clinic

    Before deciding on PGT-SR, consider asking your fertility clinic and genetic counselor the following questions:

    • What specific testing method will be used for PGT-SR, and what are its accuracy and limitations?
    • How many embryos typically reach the biopsy stage in cases like mine?
    • What is the expected turnaround time for results, and how does that affect the IVF cycle?
    • Are there any additional tests recommended, such as PGT-A for other chromosomes?
    • What are the costs involved, and are there any financial risks if no embryos are suitable for transfer?
    • What is the policy on transferring embryos with uncertain results?
    • How will the embryos be frozen and stored if needed?

    These questions can help you understand what to expect and make an informed decision.

    Next Steps and Considerations

    If you are considering PGT-SR, here is a simple checklist to guide you:

    1. Confirm your translocation diagnosis with a genetic counselor.
    2. Discuss your reproductive options, including PGT-SR, prenatal testing, and alternatives.
    3. Choose an IVF clinic with experience in PGT-SR and ask about their laboratory protocols.
    4. Understand the costs, timelines, and potential outcomes before starting.
    5. Consider the emotional and ethical aspects of embryo testing.

    Remember, PGT-SR is a personal choice. Take the time you need to gather information and support.

    Learn More

    For more information about PGT in Thailand, visit our PGT in Thailand page. You can also explore our guides and FAQ for additional insights.

    Frequently asked questions

    Is PGT-SR the same as PGT-A?

    No. PGT-A (Preimplantation Genetic Testing for Aneuploidy) screens embryos for any abnormal number of chromosomes, while PGT-SR is specifically designed to detect unbalanced rearrangements caused by a known structural rearrangement like a balanced translocation. Some clinics may combine both tests, but they are different.

    Can PGT-SR guarantee a healthy baby?

    No. PGT-SR can reduce the risk of transferring an embryo with an unbalanced translocation, but it cannot guarantee a successful pregnancy or a baby without health issues. Other genetic conditions and factors are not covered by this test.

    What happens if no embryos are suitable for transfer after PGT-SR?

    If no embryos have a normal or balanced result, you may need to consider another IVF cycle, use donor gametes, or explore other family-building options. Your clinic will discuss the possibilities based on your individual situation.

    Does PGT-SR require IVF?

    Yes, PGT-SR is performed on embryos created through IVF. It cannot be done with natural conception. If you prefer not to use IVF, prenatal testing is an alternative to consider.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs PGT-SR: What’s the Difference for Donor Egg Embryos?

    If you are using donor eggs and considering genetic testing of embryos, you may come across two common terms: PGT-A and PGT-SR. Both are types of preimplantation genetic testing (PGT), but they look for different things. PGT-A screens embryos for an abnormal number of chromosomes (aneuploidy), while PGT-SR checks for structural rearrangements of chromosomes, such as inversions or translocations. This article explains the difference, how each applies to donor egg cycles, and what to discuss with your clinic.

    At a Glance: PGT-A vs. PGT-SR

    • PGT-A (Preimplantation Genetic Testing for Aneuploidy) counts chromosomes to detect extra or missing chromosomes.
    • PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) looks for changes in chromosome structure, like deletions, duplications, inversions, or translocations.
    • PGT-A is often considered for embryos from donor eggs, especially if the donor is older or if you want to reduce the chance of transferring an embryo with an abnormal chromosome number.
    • PGT-SR is usually recommended when one or both genetic parents (including the egg donor) are known carriers of a balanced structural rearrangement.
    • Neither test guarantees a pregnancy or a healthy baby; they are screening tools that provide information to help guide embryo selection.

    What Is PGT-A?

    PGT-A, also called preimplantation genetic screening (PGS), is a test that checks embryos for the correct number of chromosomes. Humans typically have 46 chromosomes in each cell, arranged in 23 pairs. An embryo with an abnormal number of chromosomes—such as an extra copy of chromosome 21 (which causes Down syndrome) or a missing chromosome—is said to be aneuploid. Most aneuploid embryos fail to implant or result in miscarriage, and some can lead to conditions like trisomy 18 or Turner syndrome.

    PGT-A is performed on a small number of cells taken from a blastocyst (a day-5 or day-6 embryo) before transfer. The test can identify embryos that are likely to have a normal chromosome count (euploid) versus those that are aneuploid. By selecting a euploid embryo for transfer, the goal is to improve the chances of implantation and reduce the risk of miscarriage due to chromosomal abnormalities.

    Why Consider PGT-A with Donor Eggs?

    When using donor eggs, the age of the egg donor is a key factor. Younger donors (typically under 35) have a higher proportion of chromosomally normal eggs, but the risk of aneuploidy increases with maternal age. Even with a young donor, some embryos may still be aneuploid. PGT-A can help identify which embryos are most likely to be viable, potentially reducing the number of transfer cycles needed.

    However, PGT-A is not mandatory for all donor egg cycles. Some clinics may recommend it based on the donor’s age, the number of embryos available, or your personal history. It is important to discuss the potential benefits and limitations with your fertility specialist.

    What Is PGT-SR?

    PGT-SR is a test designed for couples or donors who carry a structural rearrangement of chromosomes. Structural rearrangements include:

    • Translocations: A piece of one chromosome breaks off and attaches to another chromosome. This can be balanced (no genetic material is lost or gained) or unbalanced (extra or missing genetic material).
    • Inversions: A chromosome segment breaks off, flips, and reattaches in the reverse orientation.
    • Deletions and duplications: A part of a chromosome is missing or duplicated.

    Carriers of balanced rearrangements often have no health problems themselves, but they have a higher risk of producing embryos with unbalanced chromosomes, which can lead to miscarriage, stillbirth, or a child with disabilities. PGT-SR identifies embryos that have a normal or balanced chromosome structure, so that only those are considered for transfer.

    When Is PGT-SR Relevant for Donor Eggs?

    PGT-SR is relevant when the egg donor is a known carrier of a structural rearrangement. In such cases, the donor’s eggs may carry the rearrangement, and embryos created with those eggs could be affected. If the donor has not been tested for chromosomal rearrangements, PGT-SR is not typically performed. It is also important to note that PGT-SR is different from PGT-M, which tests for specific single-gene disorders (like cystic fibrosis or sickle cell anemia).

    If you are using donor eggs, your clinic will usually have information about the donor’s genetic screening results. If the donor is a carrier of a balanced translocation or inversion, PGT-SR may be recommended. However, this is a specific situation, and most donor egg cycles do not involve PGT-SR unless there is a known indication.

    Key Differences Between PGT-A and PGT-SR

    Aspect PGT-A PGT-SR
    What it detects Abnormal number of chromosomes (aneuploidy) Structural changes in chromosomes (e.g., translocations, inversions)
    Main purpose Screen for embryos with the correct chromosome count Identify embryos with normal or balanced chromosome structure
    Who might need it Anyone, but often considered for older egg donors or when many embryos are available Only when a genetic parent (including donor) is a known carrier of a structural rearrangement
    How it works Counts chromosomes in a biopsy sample Analyzes chromosome structure, often using similar biopsy techniques
    Limitations Does not detect all genetic abnormalities; may have false positives/negatives; does not guarantee a healthy baby Only relevant for specific structural issues; does not screen for aneuploidy or single-gene disorders

    Is PGT-A Recommended for Donor Egg Cycles?

    There is no universal recommendation for PGT-A in donor egg cycles. Some clinics offer PGT-A as an option, while others may not recommend it routinely, especially if the donor is young and the embryo quality is good. The decision depends on several factors:

    • Donor age: Older donors have a higher risk of aneuploidy, so PGT-A may be more beneficial.
    • Number of embryos: If you have many embryos, PGT-A can help prioritize which to transfer first.
    • Previous pregnancy losses: If you have experienced recurrent miscarriages, PGT-A might provide additional information.
    • Personal preference: Some patients want as much information as possible before transfer.

    It is essential to have a detailed discussion with your fertility team about the potential benefits, risks, and costs of PGT-A in your specific situation. They can help you weigh the evidence and make an informed choice.

    Limitations of PGT-A and PGT-SR

    Both tests have limitations that you should understand:

    • Not diagnostic: PGT is a screening test, not a guarantee. A normal result does not ensure a healthy baby, and an abnormal result does not always mean the embryo cannot result in a live birth.
    • Mosaicism: Embryos may have a mix of normal and abnormal cells (mosaicism). PGT-A may report a mosaic result, which is challenging to interpret.
    • Technical errors: There is a small risk of false results due to the biopsy or laboratory process.
    • Embryo damage: The biopsy procedure carries a small risk of damaging the embryo, although this is rare.
    • Not for all genetic conditions: PGT-A does not screen for single-gene disorders or structural rearrangements; PGT-SR only looks for structural issues.

    It is also important to note that PGT does not eliminate the risk of miscarriage or birth defects entirely. Many other factors contribute to a successful pregnancy.

    Questions to Ask Your Clinic

    Before deciding on PGT-A or PGT-SR, consider asking your clinic the following questions:

    • What is the age of the egg donor, and does that affect the recommendation for PGT-A?
    • Has the donor been tested for chromosomal rearrangements? If so, what were the results?
    • How many embryos are expected, and how might that influence the decision?
    • What is the accuracy of the PGT test you use, and how are mosaic results handled?
    • What are the costs of PGT-A and PGT-SR, and are they included in any package?
    • How long does testing take, and how does that affect the timing of a frozen embryo transfer?
    • What are the risks of the biopsy procedure?

    Next Steps

    If you are considering PGT with donor eggs, here is a simple checklist to guide you:

    1. Review the donor’s genetic screening results with your clinic.
    2. Discuss whether PGT-A is recommended based on donor age and embryo count.
    3. Ask if PGT-SR is needed if the donor is a known carrier of a structural rearrangement.
    4. Understand the limitations and what a normal result does and does not mean.
    5. Make an informed decision that aligns with your values and medical history.

    For more information about PGT in Thailand, visit our PGT in Thailand page. You can also explore our guides and FAQ sections for additional insights.

    Frequently asked questions

    Is PGT-A necessary when using donor eggs?

    PGT-A is not always necessary. It may be recommended based on the donor's age, the number of embryos available, or your medical history. Discuss with your clinic to determine if it is beneficial for your situation.

    Can PGT-SR be done on embryos from donor eggs?

    Yes, PGT-SR can be performed if the egg donor is a known carrier of a structural chromosomal rearrangement. It is not typically done unless there is a specific indication.

    What is the difference between PGT-A and PGT-M?

    PGT-A screens for abnormal chromosome numbers, while PGT-M tests for specific single-gene disorders. They are different tests and are used for different purposes.

    Does PGT-A guarantee a healthy baby?

    No. PGT-A is a screening test that reduces the risk of transferring an embryo with an abnormal chromosome count, but it does not guarantee a pregnancy or a healthy baby. Other genetic and non-genetic factors also play a role.

    What are the risks of embryo biopsy for PGT?

    Embryo biopsy is generally safe, but there is a small risk of damaging the embryo. The procedure is performed by experienced embryologists to minimize this risk.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs PGT-SR for Male Factor Infertility: Key Differences

    Understanding PGT-A and PGT-SR

    When you are exploring fertility treatment and male factor infertility is part of the picture, you may come across two types of preimplantation genetic testing: PGT-A and PGT-SR. Both are performed on embryos created through IVF before a transfer is considered. However, they look for different things and are used in different situations.

    PGT-A (preimplantation genetic testing for aneuploidy) screens embryos for the correct number of chromosomes. PGT-SR (preimplantation genetic testing for structural rearrangements) looks for specific structural changes in chromosomes, such as inversions or translocations, that a parent may carry. Understanding the difference can help you ask the right questions and make informed decisions with your fertility team.

    At a Glance

    • PGT-A checks for extra or missing chromosomes (aneuploidy).
    • PGT-SR checks for balanced or unbalanced structural rearrangements.
    • Male factor infertility may increase the chance of sperm carrying chromosomal abnormalities.
    • Neither test guarantees a pregnancy or a healthy baby.
    • Your clinic can advise whether one or both tests are relevant for your situation.

    What Is PGT-A?

    PGT-A is a test that looks at the number of chromosomes in an embryo. Humans typically have 46 chromosomes in each cell, arranged in 23 pairs. An embryo with too many or too few chromosomes is called aneuploid. Most aneuploid embryos fail to implant or result in miscarriage. PGT-A can identify embryos that have the expected number of chromosomes, which may be prioritized for transfer.

    PGT-A is often recommended for women of advanced maternal age, but it can also be considered when there is a history of recurrent miscarriage or repeated implantation failure. In the context of male factor infertility, sperm with abnormal shape or movement may carry a higher rate of chromosomal abnormalities, which can contribute to aneuploidy in embryos.

    What Is PGT-SR?

    PGT-SR is designed for couples where one or both partners carry a structural rearrangement of their chromosomes. Structural rearrangements include translocations (when a piece of one chromosome attaches to another) and inversions (when a segment of a chromosome is reversed). These rearrangements may not affect the health of the carrier, but they can lead to embryos with unbalanced chromosomes, which may cause miscarriage or a child with disabilities.

    PGT-SR tests embryos to identify those with a balanced set of chromosomes, meaning they have the same arrangement as the carrier parent or a completely normal arrangement. This can help reduce the risk of miscarriage and the chance of passing on an unbalanced rearrangement.

    How Male Factor Infertility Relates to Chromosomal Abnormalities

    Male factor infertility is often related to sperm count, motility, or morphology. However, some men with infertility may also have chromosomal abnormalities, such as a translocation or an extra sex chromosome. Even without a diagnosed rearrangement, sperm with poor parameters may have a higher rate of chromosomal abnormalities, including aneuploidy.

    If a man carries a structural rearrangement, PGT-SR may be relevant. If there is no known rearrangement, PGT-A might be considered to screen for aneuploidy. Your fertility specialist can help determine which test, if any, is appropriate based on your medical history and diagnostic testing.

    Key Differences Between PGT-A and PGT-SR

    Aspect PGT-A PGT-SR
    What it screens for Number of chromosomes (aneuploidy) Structural changes (translocations, inversions)
    Who might consider it Couples with advanced maternal age, recurrent miscarriage, or male factor with suspected aneuploidy Couples where a parent carries a structural rearrangement
    How it works Analyzes all chromosomes for copy number Analyzes specific chromosomal regions for balanced/unbalanced arrangement
    What it can tell you Whether an embryo has the expected number of chromosomes Whether an embryo has a balanced or unbalanced structural arrangement
    Limitations Cannot detect all genetic conditions; may have false positives/negatives Cannot detect all genetic conditions; may not identify all rearrangements

    When Might PGT-A or PGT-SR Be Recommended?

    Your fertility team may suggest PGT-A if you have experienced recurrent pregnancy loss, previous aneuploidy, or if the female partner is of advanced maternal age. In male factor infertility, PGT-A might be considered if sperm analysis shows high DNA fragmentation or if there is a history of chromosomal abnormalities in the male partner.

    PGT-SR is typically recommended when a blood test (karyotype) has identified a structural rearrangement in either partner. If you have not had a karyotype test, your doctor may suggest one if there is a history of multiple miscarriages or a family history of chromosomal rearrangements.

    What PGT Cannot Do

    It is important to understand that PGT-A and PGT-SR are screening tests, not guarantees. They cannot ensure a pregnancy will occur, nor can they guarantee a healthy baby. Embryos that appear normal by these tests may still fail to implant or may have other genetic or developmental issues. Additionally, PGT does not eliminate the risk of miscarriage entirely.

    These tests also have technical limitations. For example, they require a biopsy of a few cells from the embryo, which may not represent the entire embryo (mosaicism). There is also a small risk that the biopsy could damage the embryo, though this is rare. Your clinic can explain the specific limitations and accuracy of the testing platform they use.

    Questions to Ask Your Clinic

    • Based on our history, is PGT-A or PGT-SR recommended for us?
    • What is the difference in cost between PGT-A and PGT-SR?
    • How many embryos are typically needed for testing to be worthwhile?
    • What is the accuracy of the testing method you use?
    • How will the results be reported, and who will explain them to us?
    • Are there any additional tests we should consider, such as sperm DNA fragmentation testing?

    Next Steps

    1. Review your medical history with your fertility specialist, including any previous pregnancy outcomes.
    2. Ask about genetic carrier screening and karyotype testing for both partners.
    3. Discuss whether PGT-A, PGT-SR, or both are appropriate for your situation.
    4. Understand the process, timeline, and costs involved.
    5. Make an informed decision based on your personal goals and medical advice.

    For more information about PGT in Thailand, visit our PGT in Thailand page. You can also explore our guides and FAQ sections for additional insights.

    Frequently asked questions

    Can PGT-A detect structural rearrangements like translocations?

    PGT-A is designed to detect aneuploidy (extra or missing chromosomes). It may not reliably detect balanced structural rearrangements, which is what PGT-SR is designed for. If a parent carries a translocation, PGT-SR is typically recommended.

    Is PGT-SR only for women?

    No, PGT-SR can be used when either partner carries a structural rearrangement. Male factor infertility may be linked to such rearrangements, so PGT-SR can be relevant for couples where the male partner is a carrier.

    Does male factor infertility always require PGT?

    No. PGT is not automatically required for male factor infertility. Your doctor will assess your specific situation, including sperm parameters, genetic testing results, and medical history, to determine if PGT-A or PGT-SR is beneficial.

    What is the difference between PGT-A and PGT-SR in terms of cost?

    Costs can vary between clinics and depend on the number of embryos tested. PGT-SR may be more expensive because it requires more detailed analysis. You should ask your clinic for a detailed cost breakdown.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs PGT-SR for Repeated Implantation Failure: What’s the Difference?

    If you have experienced repeated implantation failure (RIF), you may be exploring genetic testing options for embryos. Two tests often discussed are PGT-A and PGT-SR. Both are forms of preimplantation genetic testing, but they look for different types of chromosomal issues. This article explains the difference, how they might be used in RIF, and what to keep in mind.

    At a glance

    • PGT-A screens embryos for an abnormal number of chromosomes (aneuploidy).
    • PGT-SR checks for structural rearrangements of chromosomes, such as translocations.
    • Both tests require IVF and a biopsy of the embryo.
    • Neither test guarantees pregnancy or a healthy baby.

    What is PGT-A?

    PGT-A (preimplantation genetic testing for aneuploidy) is a test that looks at the number of chromosomes in an embryo. Humans typically have 46 chromosomes in each cell. An embryo with too many or too few chromosomes is called aneuploid. Most aneuploid embryos fail to implant or result in miscarriage. PGT-A aims to identify embryos with the correct number of chromosomes, which may improve the chances of implantation.

    What is PGT-SR?

    PGT-SR (preimplantation genetic testing for structural rearrangements) is used when one or both parents carry a structural chromosomal rearrangement, such as a balanced translocation or inversion. These rearrangements do not usually affect the parent’s health, but they can lead to embryos with unbalanced chromosomes, which may cause implantation failure or miscarriage. PGT-SR identifies embryos with a normal or balanced chromosomal structure.

    Key differences between PGT-A and PGT-SR

    Aspect PGT-A PGT-SR
    What it screens for Abnormal number of chromosomes (aneuploidy) Structural rearrangements (e.g., translocations, inversions)
    Who might consider it People with RIF, advanced maternal age, or previous miscarriages Couples where one partner has a known structural rearrangement
    How it works Biopsied cells are analyzed for chromosome count Biopsied cells are analyzed for chromosome structure
    Goal Select embryos with the correct number of chromosomes Select embryos with normal or balanced chromosome structure

    How PGT-A might be used in RIF

    In RIF, the cause is often unknown. PGT-A may be offered to check whether chromosomal abnormalities in embryos are contributing to implantation failure. If most embryos are aneuploid, transferring a euploid embryo might improve the chance of implantation. However, PGT-A does not address other potential causes of RIF, such as uterine factors, immune issues, or embryo-endometrium interaction.

    How PGT-SR might be used in RIF

    PGT-SR is typically considered only if a parent is known to carry a structural rearrangement. If you have RIF and a family history of translocations or repeated miscarriages, your doctor may recommend karyotyping (a blood test) for you and your partner. If a rearrangement is found, PGT-SR can help select embryos with a normal or balanced structure.

    Limitations of PGT-A and PGT-SR

    • Not a guarantee: Even a genetically normal embryo may not implant or lead to a live birth.
    • Biopsy risks: Embryo biopsy is invasive and requires skilled laboratory expertise.
    • Mosaicism: PGT-A may not always detect mosaicism (a mix of normal and abnormal cells).
    • Cost and time: Genetic testing adds to the cost of IVF and may delay embryo transfer.
    • Not for everyone: These tests are not necessary for all patients and may not be recommended in every case.

    Questions to ask your clinic

    • What is your experience with PGT-A and PGT-SR?
    • What is the biopsy technique, and how many cells are taken?
    • How are results reported, and what do they mean for my embryos?
    • What are the costs for the test and the IVF cycle?
    • How long will it take to get results?
    • What are the alternatives if I do not want genetic testing?

    Next steps

    1. Discuss your history of RIF with your fertility specialist.
    2. Ask whether genetic testing is appropriate for your situation.
    3. Consider genetic counseling to understand the implications.
    4. Review the costs and logistics with your clinic.
    5. Make an informed decision based on your personal circumstances.

    For more information, see our PGT in Thailand guide, explore our guides, or check the FAQ.

    Frequently asked questions

    Can PGT-A help with repeated implantation failure?

    PGT-A may help identify embryos with an abnormal number of chromosomes, which could be a cause of implantation failure. However, it does not address other potential causes, and a normal result does not guarantee pregnancy.

    Is PGT-SR only for people with known chromosomal rearrangements?

    Yes, PGT-SR is typically recommended when one or both parents carry a structural rearrangement, such as a translocation. If you have RIF and suspect a rearrangement, your doctor may suggest karyotyping first.

    What is the difference between PGT-A and PGT-SR?

    PGT-A screens for an abnormal number of chromosomes, while PGT-SR checks for structural rearrangements. Both require IVF and embryo biopsy, but they look for different types of chromosomal issues.

    Are PGT-A and PGT-SR guaranteed to result in a baby?

    No. Genetic testing can help select embryos with a higher chance of implantation, but it does not guarantee pregnancy or a live birth. Other factors also affect success.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs. PGT-P: Understanding Polygenic Risk Scoring in IVF

    Understanding PGT-A and PGT-P

    If you are exploring IVF with genetic testing, you may have come across terms like PGT-A and PGT-P. While both are types of preimplantation genetic testing, they serve different purposes. PGT-A (preimplantation genetic testing for aneuploidy) checks embryos for the correct number of chromosomes, while PGT-P (preimplantation genetic testing for polygenic risk scoring) estimates the likelihood of developing certain common conditions influenced by multiple genes. This article explains the key differences, the experimental status of PGT-P, and important considerations for patients.

    At a Glance

    • PGT-A: Screens for chromosomal abnormalities (aneuploidy) to select embryos with the correct chromosome number.
    • PGT-P: Estimates polygenic risk for conditions like diabetes, heart disease, or certain cancers, based on many genetic variants.
    • Status: PGT-A is widely used; PGT-P is considered experimental and not widely offered.
    • Limitations: Both tests have limitations and cannot guarantee a healthy baby.

    What Is PGT-A?

    PGT-A, previously known as preimplantation genetic screening (PGS), is a test performed on embryos created through IVF. It checks for aneuploidy—an abnormal number of chromosomes. Most embryos with aneuploidy fail to implant or result in miscarriage. By selecting embryos with the correct chromosome number, PGT-A may improve the chances of a successful pregnancy, especially for women of advanced maternal age or those with recurrent pregnancy loss.

    PGT-A is a well-established procedure in many fertility clinics. However, it is not a guarantee of pregnancy or a healthy baby. Some embryos with normal chromosomes may still fail to implant, and other factors such as uterine health and embryo quality play a role.

    What Is PGT-P?

    PGT-P is a newer, experimental test that aims to assess the risk of developing polygenic conditions—those influenced by multiple genes and environmental factors. Examples include type 2 diabetes, coronary artery disease, certain cancers, and autoimmune disorders. PGT-P uses a polygenic risk score (PRS), which aggregates the effects of many genetic variants to estimate an individual’s likelihood of developing a condition.

    Unlike PGT-A, which looks at chromosome number, PGT-P analyzes specific genetic markers associated with common diseases. The idea is to select embryos with lower polygenic risk scores, potentially reducing the chance of these conditions in offspring. However, PGT-P is not widely available and is considered experimental by many professional organizations.

    Key Differences Between PGT-A and PGT-P

    Aspect PGT-A PGT-P
    Purpose Detect chromosomal abnormalities (aneuploidy) Estimate polygenic risk for common conditions
    What it analyzes Chromosome number (23 pairs) Multiple genetic variants associated with specific diseases
    Clinical status Widely used in IVF Experimental, not widely offered
    Conditions targeted Chromosomal disorders like Down syndrome Polygenic conditions like diabetes, heart disease
    Result interpretation Normal or abnormal chromosome count Risk score (low, medium, high) for each condition
    Limitations Cannot detect all genetic abnormalities; not a guarantee Limited predictive power; ethical concerns; not clinically validated

    How PGT-P Works

    PGT-P involves several steps. After embryos are created through IVF, a few cells are biopsied from each embryo. The DNA is then analyzed for thousands of genetic variants known to influence polygenic conditions. A polygenic risk score is calculated for each embryo, and embryos with lower risk scores may be prioritized for transfer.

    However, the science behind PGT-P is still evolving. The predictive accuracy of polygenic risk scores varies by condition and population. For many conditions, the scores explain only a small fraction of the overall risk, which is also influenced by lifestyle and environment. This means that a low-risk embryo could still develop the condition, and a high-risk embryo might not.

    Limitations and Ethical Considerations

    Both PGT-A and PGT-P have limitations. PGT-A cannot detect all genetic abnormalities, such as single-gene disorders or structural rearrangements. It also cannot predict the severity of a condition if a chromosomal abnormality is present.

    PGT-P has additional limitations. It is not clinically validated, meaning its ability to predict disease risk is not well-established. There are also ethical concerns about selecting embryos based on polygenic risk, including the potential for discrimination and the psychological impact on families. Some experts worry that PGT-P may give a false sense of control, as many polygenic conditions are preventable or manageable through lifestyle changes.

    Professional organizations, such as the American Society for Reproductive Medicine (ASRM), have expressed caution about PGT-P, noting that it should be offered only in research settings until more evidence is available.

    Should You Consider PGT-P?

    If you are considering PGT-P, it is important to understand that it is not a standard part of IVF. Most clinics do not offer it, and those that do may have specific criteria. Before deciding, ask your clinic about the following:

    • Is PGT-P available at your clinic? If so, what is the process?
    • What conditions does the test screen for?
    • How accurate are the risk scores for your ethnic background?
    • What are the costs, and are they covered by insurance?
    • What are the limitations and potential risks?

    It is also crucial to consider the emotional and ethical implications. PGT-P results may cause anxiety or lead to difficult decisions. Genetic counseling is strongly recommended to help you understand the results and make informed choices.

    Questions to Ask Your Clinic

    When discussing PGT-A or PGT-P with your fertility specialist, consider asking:

    • Why do you recommend this test for my situation?
    • What are the risks of the biopsy procedure?
    • How long does it take to get results?
    • What are the success rates with and without this testing?
    • Are there alternative tests or approaches?

    Next Steps

    If you are exploring genetic testing as part of your IVF journey, start by researching reputable clinics and scheduling consultations. Ask about their experience with PGT-A and whether they offer PGT-P. Remember that no test can guarantee a healthy baby, and all decisions should be made in consultation with your medical team.

    For more information on PGT in Thailand, visit our PGT in Thailand page. You can also explore our guides and FAQ sections for additional resources.

    Frequently asked questions

    Is PGT-P the same as PGT-A?

    No, they are different tests. PGT-A checks for chromosomal abnormalities (aneuploidy), while PGT-P estimates polygenic risk for common conditions like diabetes or heart disease. PGT-P is experimental and not widely offered.

    What is a polygenic risk score?

    A polygenic risk score (PRS) is a calculation based on many genetic variants that together influence the likelihood of developing a particular condition. It is used in PGT-P to estimate an embryo's risk for polygenic diseases.

    Is PGT-P available in Thailand?

    PGT-P is not widely available anywhere, including Thailand. It is considered experimental, and most clinics do not offer it. If you are interested, you should ask your clinic directly about availability and whether they participate in research studies.

    Can PGT-P guarantee that my child won't develop a disease?

    No, PGT-P cannot guarantee that a child will not develop a polygenic condition. It only provides a risk estimate, and many factors, including lifestyle and environment, play a significant role. The predictive power of polygenic risk scores is limited.

    What are the ethical concerns with PGT-P?

    Ethical concerns include the potential for discrimination based on genetic risk, the psychological impact on families, and the risk of giving a false sense of control. Some experts worry about the lack of clinical validation and the possibility of selecting embryos for non-medical traits.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • Understanding PGT Results: What a Normal Result Means

    Waiting for preimplantation genetic testing (PGT) results can be a time of uncertainty. You may wonder what the report will show, how to interpret the terms, and what a “normal” result really means for your embryo. This guide explains the typical structure of a PGT report, defines common terms, and offers questions to ask your clinic so you can approach the results with more confidence.

    At a Glance: Key Points About PGT Results

    • PGT results are reported per embryo, not per cycle.
    • Terms like “euploid,” “aneuploid,” and “mosaic” describe the genetic status of an embryo.
    • A “normal” result means no chromosomal abnormalities were detected by the test, but it does not guarantee pregnancy or a healthy baby.
    • PGT is a screening tool, not a diagnostic test, and it has limitations.
    • Your clinic will explain the results in the context of your specific situation.

    What Is PGT and Why Is It Done?

    PGT is a test performed on embryos created through in vitro fertilization (IVF) before transfer to the uterus. It is used to identify embryos that may have certain genetic or chromosomal issues. There are three main types:

    • PGT-A (aneuploidy screening): Checks for the correct number of chromosomes. Embryos with the correct number are called “euploid,” while those with missing or extra chromosomes are “aneuploid.”
    • PGT-M (monogenic disorders): Looks for specific inherited single-gene conditions, such as cystic fibrosis or sickle cell anemia.
    • PGT-SR (structural rearrangements): Detects chromosomal structural changes, such as translocations, that may affect embryo development.

    PGT is not for everyone. It is often recommended for certain situations, such as advanced maternal age, recurrent pregnancy loss, or a known genetic condition in the family. Your clinic will advise whether PGT is appropriate for you.

    How Are PGT Results Reported?

    PGT results are typically provided in a laboratory report that lists each embryo tested and its result. The report may include:

    • Embryo identification number
    • Type of PGT performed (e.g., PGT-A)
    • Result category (e.g., euploid, aneuploid, mosaic)
    • Additional notes or recommendations

    Results are usually given as one of the following:

    • Euploid (normal): The embryo has the expected number of chromosomes (for PGT-A) or does not carry the specific genetic variant tested (for PGT-M/SR).
    • Aneuploid (abnormal): The embryo has an abnormal number of chromosomes.
    • Mosaic: The embryo has a mix of normal and abnormal cells. This is a newer category, and its implications are still being studied.
    • Inconclusive: The test did not yield a clear result, possibly due to technical issues or insufficient DNA.

    It is important to note that PGT results are not always black and white. For example, a “normal” result in PGT-A means no chromosomal abnormalities were detected, but it does not rule out all genetic conditions or guarantee a successful pregnancy.

    What Does a “Normal” Result Mean?

    A normal PGT result is reassuring, but it is not a guarantee. Here’s what it does and does not mean:

    • It means: The embryo appears to have the correct number of chromosomes (for PGT-A) or does not carry the specific genetic condition tested (for PGT-M/SR).
    • It does not mean: The embryo is guaranteed to implant, result in a live birth, or be free of all health issues. PGT cannot detect all genetic or chromosomal abnormalities, and it does not assess the embryo’s overall viability.

    In other words, a normal PGT result is a positive sign, but it is just one piece of information. Other factors, such as embryo quality, uterine environment, and overall health, also play a role.

    Understanding Mosaic Results

    Mosaic embryos have both normal and abnormal cells. The percentage of abnormal cells can vary, and the clinical significance is still being researched. Some clinics may consider transferring a mosaic embryo if no euploid embryos are available, but this decision is made on a case-by-case basis. It is essential to discuss the specific mosaic level and its potential implications with your clinic.

    Limitations of PGT

    PGT is a powerful tool, but it has limitations:

    • Not diagnostic: PGT is a screening test, not a diagnostic test. It cannot detect all genetic conditions or chromosomal abnormalities.
    • Technical limitations: The test may fail to amplify DNA or produce inconclusive results.
    • Embryo biopsy risks: The biopsy procedure, though generally safe, may have a small risk of damaging the embryo.
    • Not a guarantee: Even a normal embryo may not lead to a pregnancy due to other factors.

    Understanding these limitations can help you interpret your results with realistic expectations.

    Questions to Ask Your Clinic About PGT Results

    When you receive your PGT report, consider asking your clinic the following questions:

    • What does this result mean for my specific embryo?
    • How reliable is the test for the condition we were screening for?
    • If the result is mosaic, what is the percentage of abnormal cells, and what are the potential outcomes?
    • Are there any additional tests or follow-up steps recommended?
    • How does this result affect the decision to transfer the embryo?

    These questions can help you make an informed decision about next steps.

    Next Steps After Receiving PGT Results

    After you receive your PGT results, your clinic will discuss the options with you. These may include:

    • Transferring a euploid embryo
    • Discussing the possibility of transferring a mosaic embryo (if applicable)
    • Considering additional testing or consultation with a genetic counselor
    • Deciding whether to freeze or discard embryos based on results

    Take your time to process the information and ask for clarification if needed. Your clinic is there to support you.

    Conclusion

    PGT results can be complex, but understanding the basics can reduce anxiety and help you make informed decisions. Remember that a normal result is a positive sign, but it is not a guarantee. Always discuss your results with your clinic and ask questions to ensure you fully understand what they mean for your journey.

    Frequently asked questions

    What is the difference between PGT-A, PGT-M, and PGT-SR?

    PGT-A screens for an abnormal number of chromosomes (aneuploidy). PGT-M tests for specific single-gene disorders. PGT-SR checks for structural changes in chromosomes, such as translocations.

    Does a normal PGT result guarantee a healthy baby?

    No. A normal PGT result means no chromosomal abnormalities were detected, but it does not guarantee pregnancy, live birth, or the absence of all health issues. PGT cannot detect all genetic conditions.

    What is a mosaic embryo?

    A mosaic embryo has a mix of normal and abnormal cells. The clinical significance is still being studied, and the decision to transfer a mosaic embryo is made on a case-by-case basis.

    What should I do if my PGT result is inconclusive?

    An inconclusive result means the test did not yield a clear answer. Your clinic may recommend repeating the test, or you may consider other options. Discuss the next steps with your clinic.

    Can PGT detect all genetic disorders?

    No. PGT is a screening test that can detect specific chromosomal abnormalities or single-gene disorders, but it cannot detect all genetic conditions or birth defects.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • What PGT-A Can and Cannot Tell You: Understanding Its Limitations

    What is PGT-A?

    Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a screening test used during IVF to check embryos for an abnormal number of chromosomes. It helps embryologists select embryos that are more likely to implant and develop normally. However, PGT-A is not a guarantee of a healthy pregnancy or baby, and it has important limitations that you should understand before deciding whether to use it.

    At a Glance: Key Limitations of PGT-A

    • PGT-A cannot detect all genetic disorders, only chromosomal number abnormalities.
    • It cannot identify structural chromosome rearrangements (that’s PGT-SR).
    • It cannot detect single-gene disorders (that’s PGT-M).
    • Mosaicism results may be uncertain and require confirmatory testing.
    • PGT-A does not eliminate the risk of miscarriage or birth defects.
    • It cannot predict the health of a future child.

    What PGT-A Can Detect

    PGT-A screens for aneuploidy, which means having too many or too few chromosomes. This is a common cause of implantation failure and miscarriage. By identifying embryos with the correct number of chromosomes (euploid), PGT-A can help reduce the risk of miscarriage and improve the chances of a successful pregnancy in certain situations.

    What PGT-A Cannot Detect

    Single-Gene Disorders

    PGT-A does not test for specific genetic diseases like cystic fibrosis, sickle cell anemia, or Huntington’s disease. For those, you would need PGT-M (Preimplantation Genetic Testing for Monogenic disorders), which is a different test that looks for specific gene mutations.

    Structural Chromosome Abnormalities

    PGT-A does not detect balanced translocations or other structural rearrangements of chromosomes. If you or your partner have a known chromosomal rearrangement, PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) is the appropriate test.

    Mosaicism

    Mosaicism occurs when an embryo has both normal and abnormal cells. PGT-A may report an embryo as mosaic, meaning it has a mix of cells with different chromosome numbers. The clinical significance of mosaicism is not fully understood, and the accuracy of the result depends on the biopsy sample. A mosaic embryo may still lead to a healthy baby, but it carries a higher risk of abnormalities. Confirmatory testing, such as prenatal diagnosis (amniocentesis or CVS), is often recommended if a mosaic embryo is transferred.

    Epigenetic and Multifactorial Conditions

    PGT-A does not assess epigenetic changes (how genes are expressed) or complex conditions like autism, diabetes, or heart disease, which are influenced by multiple genes and environmental factors.

    Why PGT-A Results Are Not Absolute

    PGT-A is a screening test, not a diagnostic test. It provides information about the chromosomes in the cells biopsied from the embryo, but it cannot guarantee that the embryo is completely normal. The biopsy samples only a few cells from the trophectoderm (the part that becomes the placenta), which may not represent the entire embryo. Additionally, technical limitations can lead to false positives or false negatives.

    The Need for Confirmatory Testing

    If you become pregnant after transferring a PGT-A tested embryo, your doctor may recommend prenatal testing, such as chorionic villus sampling (CVS) or amniocentesis, to confirm the chromosomal status of the fetus. This is especially important if the embryo was mosaic or if you have other risk factors.

    Questions to Ask Your Clinic

    • What type of genetic testing does your lab use for PGT-A?
    • How does your clinic report mosaicism, and what is your policy on transferring mosaic embryos?
    • What is the accuracy rate of PGT-A at your lab?
    • Do you recommend confirmatory testing after a PGT-A pregnancy?
    • What are the costs and timelines for PGT-A?

    Next Steps: Making an Informed Decision

    Before deciding on PGT-A, discuss with your fertility specialist:

    • Your medical history and reasons for considering PGT-A.
    • The limitations and potential benefits in your specific situation.
    • Alternative options, such as not testing or using other screening methods.
    • The emotional and financial implications.

    Remember, PGT-A is a tool to help you make informed choices, but it is not a guarantee. Take your time, ask questions, and consider genetic counseling if needed.

    For more information, explore our PGT in Thailand guide, visit our guides, or check our FAQ section.

    Frequently asked questions

    Can PGT-A detect all genetic abnormalities?

    No, PGT-A only screens for an abnormal number of chromosomes (aneuploidy). It does not detect single-gene disorders, structural rearrangements, or complex conditions influenced by multiple genes and environment.

    What is mosaicism in PGT-A results?

    Mosaicism means an embryo has a mix of normal and abnormal cells. PGT-A may report an embryo as mosaic, but the clinical significance is uncertain. Confirmatory testing is often recommended if a mosaic embryo is transferred.

    Is PGT-A a guarantee of a healthy baby?

    No, PGT-A is a screening test that reduces the risk of miscarriage and chromosomal abnormalities, but it cannot guarantee a healthy pregnancy or baby. It does not detect all genetic conditions or birth defects.

    Do I need confirmatory testing after PGT-A?

    Your doctor may recommend prenatal testing, such as CVS or amniocentesis, to confirm the chromosomal status of the fetus, especially if the embryo was mosaic or you have other risk factors.

    What is the difference between PGT-A and PGT-M?

    PGT-A screens for an abnormal number of chromosomes, while PGT-M tests for specific single-gene disorders. They are used for different purposes and can be done together if needed.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • How PGT-A Affects the Number of Embryos Available for Transfer

    When you undergo IVF, the number of embryos you have can drop at several stages. PGT-A (preimplantation genetic testing for aneuploidy) is one of those stages. It screens embryos for chromosomal abnormalities before transfer. Because not all embryos will be chromosomally normal, PGT-A can reduce the number of embryos available for transfer. This article explains why that happens, what it means for your decisions, and how to plan for the possibility of needing more than one cycle.

    At a Glance

    • PGT-A tests embryos for chromosomal abnormalities.
    • Not all embryos will be normal, so the number available for transfer may decrease.
    • This reduction is part of the IVF process and can affect your timeline and decisions.
    • Planning for multiple cycles can help manage expectations.

    What Is PGT-A?

    PGT-A is a genetic test performed on embryos created through IVF. It checks for aneuploidy, which means having an abnormal number of chromosomes. Embryos with the correct number of chromosomes (46) are considered euploid and are more likely to implant and develop normally. Embryos with missing or extra chromosomes are aneuploid and may fail to implant or result in miscarriage.

    PGT-A is not a guarantee of a successful pregnancy, but it provides information that can help you and your clinic decide which embryos to transfer.

    How PGT-A Reduces the Number of Usable Embryos

    During IVF, you may produce several embryos. After fertilization, embryos are cultured for a few days. At the blastocyst stage, a few cells are biopsied and sent for PGT-A testing. The results typically categorize embryos as:

    • Euploid: normal chromosome number, suitable for transfer.
    • Aneuploid: abnormal chromosome number, generally not recommended for transfer.
    • Mosaic: a mix of normal and abnormal cells, which may have reduced potential.

    Because a significant proportion of embryos can be aneuploid, especially as maternal age increases, the number of embryos that are suitable for transfer may be lower than the total number of embryos you produce. This is often called embryo attrition.

    What This Means for Your Decision-Making

    Knowing that PGT-A can reduce the number of available embryos helps you prepare emotionally and practically. Here are some key points to consider:

    • Expect attrition: It is normal for not all embryos to be normal. Discuss with your clinic what percentage of embryos typically come back as euploid for your age group.
    • Transfer decisions: If you have fewer euploid embryos, you may need to decide how many to transfer in a single cycle. Your clinic will guide you based on your situation.
    • Consider all options: If you have no euploid embryos, you may need to consider another IVF cycle, using donor eggs, or other alternatives. Your clinic can discuss these options with you.

    Planning for Multiple Cycles

    Because PGT-A can reduce the number of transferable embryos, it is wise to plan for the possibility of more than one IVF cycle. Here are some steps to consider:

    1. Discuss your goals: Talk to your clinic about how many embryos you hope to have for transfer and whether you are open to multiple cycles.
    2. Understand your ovarian reserve: Your age and ovarian reserve affect how many eggs you are likely to produce. This can influence the number of embryos you may get.
    3. Budget and time: Multiple cycles involve additional time and cost. Ask your clinic for a breakdown of costs per cycle and any package deals.
    4. Emotional preparation: The uncertainty of embryo numbers can be stressful. Consider counseling or support groups.

    Questions to Ask Your Clinic

    To make informed decisions, ask your clinic the following questions:

    • What is the expected attrition rate from eggs to blastocysts and then to euploid embryos for someone my age?
    • How many embryos do you recommend we aim for before considering transfer?
    • What are the options if we have no euploid embryos?
    • Are there any additional tests or procedures that might help?

    Next Steps

    If you are considering PGT-A, take these steps:

    1. Consult with a fertility specialist to understand if PGT-A is right for you.
    2. Ask for a detailed explanation of the testing process and what the results mean.
    3. Plan financially and emotionally for the possibility of multiple cycles.
    4. Explore resources on PGT in Thailand and general guides to help you prepare.

    Remember, PGT-A is a tool to provide information, not a guarantee. The number of embryos available for transfer can be lower than expected, but this knowledge helps you make the best decisions for your family-building journey.

    Frequently asked questions

    Does PGT-A always reduce the number of embryos available?

    Not always, but it can. PGT-A identifies embryos with chromosomal abnormalities, and those are typically not transferred. The reduction depends on factors like maternal age and embryo quality. Some patients may have many euploid embryos, while others may have few or none.

    What happens if I have no euploid embryos after PGT-A?

    If no embryos are euploid, your clinic will discuss options such as another IVF cycle, using donor eggs, or considering mosaic embryos. The decision depends on your individual situation and should be made with your medical team.

    Can PGT-A improve my chances of pregnancy?

    PGT-A can help select embryos that are more likely to implant, but it does not guarantee pregnancy. It may reduce the risk of miscarriage due to chromosomal abnormalities, but other factors also affect success.

    Is PGT-A recommended for everyone?

    No. PGT-A is often recommended for women over 35, those with recurrent miscarriage, or previous failed IVF cycles. However, it is not necessary for everyone. Your clinic can advise based on your medical history.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A, PGT-M, and PGT-SR: What’s the Difference?

    If you are exploring IVF and preimplantation genetic testing (PGT), you may have come across terms like PGT-A, PGT-M, and PGT-SR. These are three distinct types of genetic testing that can be performed on embryos before transfer. Understanding what each test does—and what it does not do—can help you ask better questions and make more informed decisions with your fertility team.

    In simple terms: PGT-A checks for the correct number of chromosomes, PGT-M looks for a specific single-gene disorder, and PGT-SR checks for structural changes in chromosomes. Each test serves a different purpose and is used in different clinical situations. This guide explains the basics, the limitations, and the questions you may want to ask your clinic.

    At a Glance: The Three PGT Types

    • PGT-A (Aneuploidy Screening): Counts chromosomes to identify embryos with an abnormal number (aneuploidy).
    • PGT-M (Monogenic Disorders): Tests for a specific inherited condition caused by a single gene, such as cystic fibrosis or sickle cell disease.
    • PGT-SR (Structural Rearrangements): Detects unbalanced chromosome rearrangements, such as translocations or inversions.

    What Is PGT-A?

    PGT-A, previously known as preimplantation genetic screening (PGS), is designed to detect an abnormal number of chromosomes in an embryo. Humans typically have 46 chromosomes in each cell. An embryo with too many or too few chromosomes is said to be aneuploid. Most aneuploid embryos fail to implant or result in miscarriage, though some can lead to conditions like Down syndrome (trisomy 21).

    PGT-A is often considered for patients who want to reduce the risk of miscarriage or who have had repeated implantation failure. It may also be used in cases of advanced maternal age, where the likelihood of aneuploidy is higher. However, PGT-A does not guarantee a successful pregnancy, and it cannot detect all genetic abnormalities.

    How PGT-A Works

    During an IVF cycle, embryos are cultured for several days until they reach the blastocyst stage. A small number of cells are then removed from the outer layer of the embryo (trophectoderm) and sent for genetic analysis. The embryo is frozen while the results are pending. Only embryos with the expected number of chromosomes are considered for transfer.

    Limitations of PGT-A

    PGT-A is not a test for every genetic condition. It does not screen for single-gene disorders or structural rearrangements. Additionally, because the test is performed on a few cells, there is a small chance that the results may not perfectly reflect the entire embryo (a phenomenon called mosaicism). Your clinic can explain how they interpret mosaic results.

    What Is PGT-M?

    PGT-M, formerly known as preimplantation genetic diagnosis (PGD), is used when one or both parents carry a known genetic mutation for a specific single-gene disorder. This test identifies embryos that have inherited the mutation, allowing the transfer of embryos that are unaffected.

    PGT-M is typically offered to couples who have a family history of a genetic condition, such as cystic fibrosis, Tay-Sachs disease, or Huntington’s disease. It requires prior knowledge of the exact genetic mutation, which is usually confirmed through carrier screening or genetic testing of the parents.

    How PGT-M Works

    Before starting an IVF cycle, the clinic may need to develop a personalized test for the specific mutation. This often involves a “work-up” phase where DNA samples from the parents and sometimes other family members are analyzed. Once the test is ready, embryos are biopsied and tested for the presence of the mutation. Only embryos without the mutation are considered for transfer.

    Limitations of PGT-M

    PGT-M is highly specific to the tested mutation. It does not screen for other genetic conditions or chromosomal abnormalities unless combined with PGT-A. The process can be time-consuming and may require additional planning. It is also not available for every genetic condition, so you should confirm with your clinic whether your specific situation can be tested.

    What Is PGT-SR?

    PGT-SR is used when one or both parents have a structural rearrangement of their chromosomes, such as a translocation or inversion. These rearrangements may not cause health problems in the parent, but they can lead to embryos with unbalanced chromosomes, which may result in miscarriage, stillbirth, or a child with disabilities.

    PGT-SR identifies embryos with balanced chromosomes, meaning they have the correct amount of genetic material. This test is often recommended for couples who have experienced recurrent miscarriages or who have a known chromosomal rearrangement.

    How PGT-SR Works

    Like PGT-A, PGT-SR involves embryo biopsy and genetic analysis. The laboratory looks for specific structural abnormalities in the chromosomes. The process may be combined with PGT-A to also check for aneuploidy, as structural rearrangements can increase the risk of aneuploidy.

    Limitations of PGT-SR

    PGT-SR does not correct the rearrangement; it only helps select embryos that are balanced. It also does not detect all types of chromosomal abnormalities. As with other PGT types, there is a small risk of misdiagnosis, and the test cannot guarantee a healthy baby.

    Comparing PGT-A, PGT-M, and PGT-SR

    Feature PGT-A PGT-M PGT-SR
    What it screens for Abnormal number of chromosomes (aneuploidy) Specific single-gene disorder Structural chromosome rearrangements
    Typical reason for testing Advanced maternal age, repeated implantation failure, recurrent miscarriage Known genetic mutation in one or both parents Known chromosomal rearrangement in a parent
    Requires prior genetic information No Yes, the specific mutation must be known Yes, the rearrangement must be identified
    Can be combined with other PGT Yes, often combined with PGT-M or PGT-SR Yes, often combined with PGT-A Yes, often combined with PGT-A
    Does it guarantee a healthy baby? No No No

    Which Test Is Right for You?

    The choice of PGT type depends on your medical history, genetic background, and the reason for undergoing IVF. There is no one-size-fits-all answer. Your fertility specialist and a genetic counselor can help you determine whether PGT is appropriate and which type(s) may be beneficial.

    For example, if you are over 35 and concerned about aneuploidy, PGT-A might be discussed. If you and your partner are carriers of a recessive disorder, PGT-M may be offered. If you have a translocation, PGT-SR could be recommended. In some cases, a combination of tests may be used.

    Questions to Ask Your Clinic

    • What type of PGT do you recommend for my situation, and why?
    • What is the process for embryo biopsy, and how many cells are removed?
    • How long does it take to get results, and will my embryos be frozen in the meantime?
    • What are the risks and limitations of the recommended test?
    • How does your laboratory handle mosaicism or inconclusive results?
    • What are the costs involved, and are they included in the IVF package?

    Alternatives and Additional Considerations

    PGT is not the only way to assess embryo health. Some patients may choose not to undergo PGT and instead rely on embryo morphology (appearance) for selection. Others may consider prenatal testing during pregnancy, such as chorionic villus sampling or amniocentesis, to confirm genetic status.

    It is also important to note that PGT does not eliminate all risks. Even with PGT, there is a small chance of misdiagnosis, and not all genetic conditions can be tested. Furthermore, PGT does not guarantee implantation, pregnancy, or a live birth.

    Next Steps

    If you are considering PGT, start by gathering your medical records and any genetic test results. Consult with a fertility specialist who can explain the options in the context of your specific situation. A genetic counselor can also provide valuable insight into the implications of testing.

    When researching clinics, ask about their experience with PGT, their laboratory protocols, and how they communicate results. You may also want to explore our PGT in Thailand page for an overview of what to consider when seeking treatment abroad.

    For more general information, visit our guides section, or check the FAQ for common questions about fertility treatment.

    Frequently asked questions

    Can PGT-A, PGT-M, and PGT-SR be done at the same time?

    Yes, it is possible to combine PGT-A with PGT-M or PGT-SR in a single biopsy. This allows the laboratory to check for aneuploidy as well as the specific genetic condition or structural rearrangement. However, not all clinics offer combined testing, and the feasibility may depend on the laboratory's protocols and the amount of DNA available from the biopsy.

    Does PGT guarantee a healthy baby?

    No. PGT can reduce the risk of transferring an embryo with a specific genetic abnormality, but it cannot guarantee a successful pregnancy or a healthy baby. There are many factors that affect pregnancy outcomes, and PGT does not screen for all possible genetic or developmental issues.

    Is PGT mandatory for all IVF patients?

    No, PGT is not mandatory. It is an optional test that may be recommended based on your medical history, age, or genetic background. Some patients choose not to undergo PGT, and the decision should be made in consultation with your fertility specialist and genetic counselor.

    What is the difference between PGT-A and PGT-M?

    PGT-A screens for an abnormal number of chromosomes (aneuploidy), while PGT-M tests for a specific single-gene disorder. PGT-A is often used to improve the chances of implantation and reduce miscarriage risk, whereas PGT-M is used when parents carry a known genetic mutation.

    How long does PGT take?

    The time required for PGT can vary. After embryo biopsy, results may take several days to a few weeks, depending on the laboratory and the type of test. During this time, embryos are typically frozen. Your clinic can provide a more specific timeline based on their procedures.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • How Long Does PGT-A Biopsy Take and Does It Add Time to an IVF Cycle in Thailand?

    If you are considering preimplantation genetic testing for aneuploidy (PGT-A) as part of an IVF cycle in Thailand, you likely want to know how the biopsy step fits into your overall timeline. The biopsy itself is a short procedure, but the full impact on your cycle depends on several factors, including embryo development, laboratory scheduling, and the testing method used. This guide explains the process and helps you plan your travel and expectations.

    At a Glance: PGT-A Biopsy and IVF Timeline

    • Biopsy procedure: A few minutes per embryo, performed by an embryologist.
    • Timing: Usually occurs on day 5 or day 6 of embryo development (blastocyst stage).
    • Result wait: Typically several days to a couple of weeks, depending on the testing method and lab.
    • Cycle impact: The biopsy adds a laboratory step, but the main time consideration is the wait for results before a frozen embryo transfer.

    What Is PGT-A Biopsy?

    PGT-A is a genetic test that screens embryos for an abnormal number of chromosomes (aneuploidy). To perform the test, a small number of cells are removed from the outer layer of the embryo (trophectoderm), which will later become the placenta. This is called a biopsy. The embryo itself is not harmed; the cells are taken from the part that does not become the baby.

    The biopsy is performed by an embryologist using a precise laser and a tiny pipette. It is a delicate procedure that requires skill and experience. The entire biopsy process for one embryo typically takes only a few minutes, but the laboratory must also prepare the cells for genetic analysis.

    How the Biopsy Fits into the IVF Timeline

    In a standard IVF cycle, eggs are retrieved, fertilized, and embryos are cultured in the laboratory for about five to six days until they reach the blastocyst stage. At this point, the embryologist can assess the embryo’s quality and, if PGT-A is planned, perform the biopsy.

    The biopsy is usually done on day 5 or day 6 after fertilization. After the biopsy, the embryos are frozen (vitrified) while the genetic analysis takes place. This means that the embryo transfer is delayed until the results are available, which is typically in a subsequent menstrual cycle.

    Therefore, the biopsy itself does not add significant time to the laboratory phase, but the wait for results does extend the overall timeline before a frozen embryo transfer can occur.

    How Long Do PGT-A Results Take?

    The time to receive PGT-A results varies depending on the testing method and the laboratory’s workflow. Some techniques, such as next-generation sequencing (NGS), may provide results in a few days, while others might take longer. In Thailand, many clinics send samples to specialized genetic laboratories, which may add shipping time.

    Typically, you can expect to wait anywhere from a few days to two weeks for results. Your clinic will give you a more specific estimate based on their protocols and the laboratory they use. It is important to ask about this timeline during your consultation so you can plan your stay or travel arrangements.

    Does PGT-A Add Time to the Overall IVF Cycle?

    Yes, PGT-A adds time to the overall IVF cycle, but not because of the biopsy itself. The main time addition is the delay between embryo biopsy and transfer, as you must wait for the genetic results. In a fresh embryo transfer cycle, the transfer would typically occur on day 5 or 6 after egg retrieval. With PGT-A, the transfer is postponed to a later cycle, usually after the results are available and the embryo has been frozen.

    This means that the total time from egg retrieval to embryo transfer can be extended by several weeks to a couple of months, depending on your clinic’s scheduling and your own menstrual cycle. However, many patients find that the benefit of knowing the chromosomal status of their embryos outweighs the additional wait.

    Planning Your IVF Cycle in Thailand with PGT-A

    If you are traveling to Thailand for IVF with PGT-A, it is essential to plan for the extended timeline. Here are some practical considerations:

    • Duration of stay: You may need to stay in Thailand for the initial monitoring, egg retrieval, and embryo biopsy, which typically takes about two to three weeks. After that, you can return home while waiting for results, and then come back for the frozen embryo transfer.
    • Communication: Ensure your clinic has a clear system for sharing results and scheduling your transfer, especially if you are not in the country.
    • Flexibility: Be prepared for potential delays, such as laboratory turnaround times or the need to repeat a cycle if no embryos are suitable for biopsy.

    Questions to Ask Your Clinic

    To get a clear picture of your timeline, ask your clinic the following questions:

    • On which day of embryo development do you typically perform the biopsy?
    • How long does the biopsy procedure take for a single embryo?
    • What is the expected turnaround time for PGT-A results?
    • Do you send samples to an external laboratory? If so, how does that affect the timeline?
    • How soon after receiving results can I schedule a frozen embryo transfer?
    • What is your policy for communicating results and coordinating with international patients?

    Next Steps: Your Checklist

    • Consult with your fertility specialist to determine if PGT-A is appropriate for your situation.
    • Ask for a detailed timeline that includes the biopsy and result wait.
    • Plan your travel and accommodation with flexibility for potential delays.
    • Discuss the costs of PGT-A, including biopsy, testing, and any additional shipping or storage fees.
    • Clarify how your embryos will be frozen and stored while awaiting results.

    Understanding the biopsy process and its impact on your IVF timeline can help you make informed decisions and reduce stress. While the wait for results can be anxious, it is a step that provides valuable information for your family-building journey.

    Frequently asked questions

    Is the PGT-A biopsy painful for the embryo?

    The embryo does not have nerves, so it does not feel pain. The biopsy removes a few cells from the outer layer, and the embryo continues to develop normally in the laboratory.

    Can PGT-A be done on day 3 embryos?

    While it is possible to biopsy embryos at the cleavage stage (day 3), it is more common and generally considered safer to biopsy at the blastocyst stage (day 5 or 6) because more cells can be removed without affecting the embryo's viability.

    Does PGT-A guarantee a successful pregnancy?

    No, PGT-A does not guarantee pregnancy or a healthy baby. It screens for chromosomal abnormalities, but it cannot detect all genetic conditions or ensure implantation. Many other factors affect the outcome.

    How long after PGT-A results can I have a frozen embryo transfer?

    The timing depends on your clinic's protocols and your own menstrual cycle. Typically, you may need to wait for your next cycle after receiving results, but your clinic will provide specific instructions.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.